Getting vaccinated against Coxsackie B viruses (CVB) may help prevent people with cystic fibrosis (CF) from getting ill, according…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Voting is now open for the 2022 Thriving Undergraduate and Thriving Graduate Scholarships — a grant program for students with…
Treatment with ELX-02 in combination with Kalydeco (ivacaftor) was well-tolerated, but failed to meet efficacy goals in a…
People with cystic fibrosis (CF) who have abnormal glucose tolerance — higher-than-normal blood sugar levels after eating — are…
People with cystic fibrosis (CF) treated with Kalydeco (ivacaftor) may have higher levels of the medication in their…
Treatment with the triple-combination therapy Trikafta improved lung function and eased respiratory symptoms for school-aged children with cystic…
Efforts to promote physical activity in people with cystic fibrosis (CF) should be holistically integrated into routine care, rather…
Targeting a protein called eRF3a may offer a way of treating cystic fibrosis (CF) caused by nonsense mutations, potentially…
More than half of adults with cystic fibrosis (CF) who underwent assessments of bone mineral density at a U.S.
Among babies with cystic fibrosis (CF) identified via newborn screening, there are marked delays in the start of care…